Simulations shed light on heart-scarring similarities among patients with atrial fibrillation and those who had embolic stroke but no atrial fibrillation.
Investigators hope leading-edge scientific studies will translate into therapies for difficult-to-treat skeletal muscle disorders, as well as heart muscle damage
One idea for treating disease is to be able to program cells. Now, a major advance in synthetic biology allows for that kind of control that hasn't been seen before.
